Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/90610
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Progression of coronary atherosclerosis in African-American patients |
Author: | Kataoka, Y. Hsu, A. Wolski, K. Uno, K. Puri, R. Tuzcu, E. Nissen, S. Nicholls, S. |
Citation: | Cardiovascular diagnosis and therapy, 2013; 3(3):161-169 |
Publisher: | AME Publishing |
Issue Date: | 2013 |
ISSN: | 2223-3652 2223-3660 |
Statement of Responsibility: | Yu Kataoka, Amy Hsu, Kathy Wolski, Kiyoko Uno, Rishi Puri, E. Murat Tuzcu, Steven E. Nissen, Stephen J. Nicholls |
Abstract: | BACKGROUND: African-Americans with coronary artery disease (CAD) demonstrate worse clinical outcomes than Caucasians. While this is partly due to a lack of accessibility to established therapies, the mechanisms underlying this difference remain to be elucidated. We aimed to characterize the progression of coronary atherosclerosis in African-Americans with CAD. METHODS: 3,479 patients with CAD underwent serial intravascular ultrasound (IVUS) imaging to evaluate atheroma progression in 7 clinical trials of anti-atherosclerotic therapies. Risk factor control and atheroma progression were compared between African-Americans (n=170) and Caucasians (n=3,309). RESULTS: African-Americans were more likely to be female (51.8% vs. 28.1%, P<0.001), have a higher body mass index (32.8±6.0 vs. 31.3±5.8 kg/m(2), P=0.002) and greater history of hypertension (85.9% vs. 78.8%, P=0.02), diabetes (41.8% vs. 30.6%, P=0.002) and stroke (12.9% vs. 3.0%, P<0.001). Despite a high use of anti-atherosclerotic medications (93% statin, 89% aspirin, 79% β-blocker, 52% ACE inhibitor), African-Americans demonstrated higher levels of LDL-C (2.4±0.7 vs. 2.2±0.7 mmol/L, P=0.006), CRP (2.9 vs. 2.0 mg/dL, P<0.001) and systolic blood pressure (133±15 vs. 129±13 mmHg, P<0.001) at follow-up. There was no significant difference in atheroma volume at baseline (189.0±82.2 vs. 191.6±83.3 mm(3), P=0.82) between two groups. Serial evaluation demonstrated a greater increase in atheroma volume in African-Americans (0.51±2.1 vs. -3.1±1.7 mm(3), P=0.01). This difference persisted with propensity matching accounting for differences in risk factor control (0.1±2.1 vs. -3.7±1.7 mm(3), P=0.02). CONCLUSIONS: African-Americans with CAD achieve less optimal risk factor control and greater atheroma progression. These findings support the need for more intensive risk factor modification in African-Americans. |
Keywords: | African-American coronary atherosclerosis intravascular ultrasound (IVUS) |
Rights: | Copyright status unknown |
DOI: | 10.3978/j.issn.2223-3652.2013.08.05 |
Appears in Collections: | Aurora harvest 2 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.